News
Through its recently unveiled Priority Voucher program, the FDA seeks to accelerate the review process for companies that ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Shkreli's Turing Pharmaceuticals raised the price of an anti-parasitic drug from $13.50 to over $750 overnight, sparking ...
The central government has regulated prices for 71 essential medicines. This includes drugs for breast cancer, allergies, and diabetes. Reliance Life Sciences' Trastuzumab is now capped at Rs 11,966 ...
A Trump administration proposal to consider another form of drugs for Medicare price cuts is spurring legal and policy ...
Medicare inflation rebates fail to curb rising drug prices, highlighting the need for further policy action to control costs.
Missourians simply cannot afford their prescription drugs. More than one in four have skipped doses or split pills to make prescriptions last longer. Over half worry they won’t be able to afford their ...
Prescription price controls and importing inferior medications will hurt both patients and America’s standards. We should ...
The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...
FTC investigators documented how pharmacy benefit managers imposed eye-popping markups on generic drugs used to treat deadly ...
The fact that lenacapavir will soon be available to patients is a testament to the strength of America's biopharmaceutical ...
U.S. Reps. Raja Krishnamoorthi, D-Ill., and Earl “Buddy” Carter, R-Ga., along with nine other representatives, introduced a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results